You are here: Home: BCU 4|2004: Faculty disclosures

FACULTY DISCLOSURES

As a provider accredited by the ACCME, it is the policy of Research To Practice to require significant financial interest or any other relationship the sponsor or faculty members have with the any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:

Martine Piccart, MD, PhD
Grants/Research Support: Aventis Pharmaceuticals Inc, Novartis Pharmaceuticals,
Ortho Biotech Products LP
Consultant: AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc, Bristol-Myers Squibb Company, GlaxoSmithKline, Novartis Pharmaceuticals

Larry Norton, MD
No financial interests or affiliations to disclose

Kent Osborne, MD
Grants/Research Support: AstraZeneca Pharmaceuticals LP, Merck and Company Inc Consultant: AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals, Pfizer Inc Honorarium: Pfizer Inc

Maria Theodoulou, MD
Grants/Research Support: Elan Corporation, Roche Laboratories Inc Honorarium: Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech BioOncology, Roche Laboratories Inc

This educational activity contains discussion of published and/or investigational uses of agents that are by the Food and Drug Administration. Research To Practice does not recommend the use of any labeled indications. Please refer to the official prescribing information for each product for discussion indications, contraindications and warnings. The opinions expressed are those of the presenters and construed as those of the publisher or grantor.

Table of Contents Top of Page

 

 

Home · Search

 
Editor’s Note:
Dr Piccart’s mother
 
Martine Piccart, MD, PhD and Larry Norton, MD
- Select publications
 
Martine Piccart, MD, PhD
- Select publications
 
C Kent Osborne, MD
- Select publications
 
Maria Theodoulou, MD
- Select publications
 
PowerPoint® Atlas: HER2 and Adjuvant Trastuzumab
 
Editor's Office
Faculty Disclosures
CME Information
Home · Contact us
Terms of use and general disclaimer